DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)



company name or ticker
Company Photos
(Click to zoom)

AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study - Analyst Blog

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog

Dividend Aristocrats In Focus Part 45: AbbVie

Mixed Readings For Biotech Short Interest

My Strategy For Objective, Emotionless Dividend Growth Investing

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

Health Care Sector Update for 11/26/2014: ARWR, AMGN, AZN

Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog

3 Stocks Underperforming Today In The Drugs Industry

I'm Letting Amgen Cool Down Before Buying Any More Shares Right Now

See More Articles...